Jupiter Neurosciences
$0.37
10
-$0.01-2.9% Thursday 20:00
Statistics
Day High
0.38
Day Low
0.36
52W High
3.33
52W Low
0.31
Volume
42,080
Avg. Volume
322,454
Mkt Cap
12.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.05
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-5.51MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JUNS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.
Show more...
CEO
Mr. Christer Rosen
Employees
4
Country
US
ISIN
US48208B2034
Listings
0 Comments
Share your thoughts
FAQ
What is Jupiter Neurosciences stock price today?▼
The current price of JUNS is $0.37 USD — it has decreased by -2.9% in the past 24 hours. Watch Jupiter Neurosciences stock price performance more closely on the chart.
What is Jupiter Neurosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Jupiter Neurosciences stocks are traded under the ticker JUNS.
Is Jupiter Neurosciences stock price growing?▼
JUNS stock has risen by +5.34% compared to the previous week, the month change is a -12.19% fall, over the last year Jupiter Neurosciences has showed a -37.19% decrease.
What is Jupiter Neurosciences market cap?▼
Today Jupiter Neurosciences has the market capitalization of 12.69M
When is the next Jupiter Neurosciences earnings date?▼
Jupiter Neurosciences is going to release the next earnings report on June 03, 2026.
What is Jupiter Neurosciences revenue for the last year?▼
Jupiter Neurosciences revenue for the last year amounts to 0 USD.
What is Jupiter Neurosciences net income for the last year?▼
JUNS net income for the last year is -5.51M USD.
How many employees does Jupiter Neurosciences have?▼
As of April 05, 2026, the company has 4 employees.
In which sector is Jupiter Neurosciences located?▼
Jupiter Neurosciences operates in the Health Care sector.
When did Jupiter Neurosciences complete a stock split?▼
Jupiter Neurosciences has not had any recent stock splits.
Where is Jupiter Neurosciences headquartered?▼
Jupiter Neurosciences is headquartered in Jupiter, US.